Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, China.
Weifang People's Hospital Affiliated to Weifang Medical University, Weifang, China.
J Craniofac Surg. 2023 Oct 1;34(7):e632-e636. doi: 10.1097/SCS.0000000000009437. Epub 2023 Jun 19.
Vertebrobasilar dolichoectasia (VBD) is a rare disease in clinic, with an incidence of 0.06% and 5.8%. It is a progressive vascular disease caused by the dilatation, tortuosity, and prolongation of vertebral and basilar arteries caused by a variety of factors. VBD can lead to hemodynamic changes, ischemic stroke, compression symptoms due to vasodilation, neurological dysfunction, hydrocephalus, subarachnoid hemorrhage, and other clinical manifestations. However, because the condition of VBD is complex and changeable, the treatment of VBD is not uniform. With the development of vascular intervention, especially the development of stent technology, it may become an effective method for the treatment of VBD. Two patients with VBD were treated with endovascular stent implantation.
椎基底动脉延长扩张症（VBD）是临床少见疾病，发病率为 0.06%~5.8%。它是一种由多种因素引起的椎动脉和基底动脉扩张、迂曲、延长的进行性血管疾病。VBD 可导致血流动力学改变、缺血性脑卒中、血管扩张引起的压迫症状、神经功能障碍、脑积水、蛛网膜下腔出血等临床表现。但是，由于 VBD 病情复杂多变，VBD 的治疗并不统一。随着血管介入的发展，尤其是支架技术的发展，可能成为治疗 VBD 的有效方法。对 2 例 VBD 患者采用血管内支架植入术治疗。
